PlexusDx sells semaglutide and tirzepatide through its own Weight Management Protocols and is unaffiliated with Ivim Health
These injection site reactions are usually mild to moderate in severity and tend to resolve spontaneously within days to up to two weeks without requiring medical intervention
Patients may report a predominance of diarrhea (IBS-D) or constipation (IBS-C), but both may occur in an individual patient
Testing often starts with a medical history, examination, complete blood count, and serum total B12 or active B12, depending on local practice
It is unestablished : the small, non-independent human record reports few adverse events, and that record is too narrow to support any general safety claim
The research literature and clinical experience point toward a few well-established approaches